Bruce & Co., Inc. Durect Corp Transaction History

Bruce & Co., Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2017 Feb 14, 2018	SELL	$0.78 - $2.1 $380,727 - $1.03 Million	-488,112 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$1.55 - $1.82 $756,573 - $888,363	488,112	488,112 $863,000

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $216M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Bruce & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on Bruce & Co., Inc. with notifications on news.